Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (IPDGC-NIA) C UKPDSBB CL 937 (40%) 1896 (53%) 58 (13) - - - 63 (10) - 9,622

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs2123511 chr2:236923187 AGAP1 C vs. T All: C 15 108,990 0.358 (C) 0.483 (C) 0.92 (0.89-0.95) 3 (0-55) 2.55e-07
rs1349732 chr2:236923716 AGAP1 G vs. A All: C 15 108,990 0.358 (G) 0.483 (G) 0.92 (0.89-0.95) 8 (0-44) 2.30e-07
rs1349731 chr2:236924047 AGAP1 A vs. G All: C 15 108,990 0.358 (A) 0.483 (A) 0.92 (0.89-0.95) 3 (0-55) 2.58e-07
rs7596780 chr2:236924303 AGAP1 C vs. T All: C 15 108,990 0.358 (C) 0.483 (C) 0.92 (0.89-0.95) 5 (0-56) 3.79e-07
rs7569558 chr2:236924309 AGAP1 G vs. A All: C 15 108,990 0.358 (G) 0.483 (G) 0.92 (0.89-0.95) 6 (0-56) 3.76e-07
rs9636243 chr2:236925259 AGAP1 G vs. A All: C 15 108,990 0.358 (G) 0.483 (G) 0.92 (0.89-0.95) 8 (0-45) 2.34e-07
rs7565059 chr2:236926347 AGAP1 A vs. G All: C 15 108,990 0.358 (A) 0.467 (A) 0.92 (0.89-0.95) 8 (0-45) 2.16e-07
rs7558353 chr2:236927888 AGAP1 C vs. T All: C 15 108,990 0.483 (C) 0.35 (T) 0.93 (0.90-0.96) 7 (0-43) 7.94e-06
rs1349729 chr2:236928217 AGAP1 A vs. G All: C 15 108,990 0.367 (A) 0.467 (A) 0.92 (0.89-0.95) 9 (0-47) 1.86e-07
rs7557044 chr2:236932554 AGAP1 C vs. T All: C 15 108,990 0.358 (C) 0.5 (C) 0.92 (0.89-0.95) 6 (0-56) 2.28e-07
rs10929159 chr2:236932963 AGAP1 T vs. G All: C 15 108,990 0.358 (T) 0.492 (T) 0.92 (0.89-0.95) 0 (0-53) 1.53e-07
rs10200358 chr2:236935791 AGAP1 A vs. G All: C 15 108,990 0.358 (A) 0.5 (A) 0.92 (0.89-0.95) 2 (0-55) 2.00e-07
rs11692136 chr2:236936377 AGAP1 T vs. C All: C 15 108,990 0.35 (T) 0.5 (T) 0.92 (0.89-0.95) 0 (0-54) 2.37e-07
rs10170434 chr2:236937578 AGAP1 G vs. A All: C 15 108,990 0.35 (G) 0.492 (G) 0.92 (0.89-0.95) 6 (0-56) 2.56e-07
rs6758225 chr2:236939412 AGAP1 G vs. A All: C 15 108,990 0.358 (G) 0.5 (G) 0.92 (0.89-0.95) 7 (0-43) 3.11e-07
rs765880 chr2:236940317 AGAP1 C vs. A All: C 15 108,990 0.367 (C) 0.5 (C) 0.92 (0.89-0.95) 7 (0-43) 2.64e-07
rs876739 chr2:236943672 AGAP1 C vs. T All: C 15 108,990 0.35 (C) 0.5 (C) 0.92 (0.89-0.95) 9 (0-47) 4.52e-07
rs3754659 chr2:236950634 AGAP1 A vs. G All: C 15 108,990 0.35 (A) 0.458 (A) 0.92 (0.90-0.96) 20 (0-56) 1.93e-06
rs472247 chr2:239362573 ASB1 [+1682bp] G vs. A All: C 15 108,990 0.475 (G) 0.333 (A) 1.06 (1.03-1.10) 37 (0-66) 1.26e-04
rs551859 chr2:239371836 ASB1 [+10945bp] T vs. C All: C 15 108,990 0.475 (T) 0.375 (C) 1.07 (1.03-1.10) 37 (0-66) 7.77e-05
rs11131168 chr3:998513 intergenic A vs. G All: C 15 108,990 0.425 (A) 0.35 (G) 1.07 (1.03-1.10) 0 (0-28) 6.85e-05
rs17436070 chr3:1003326 intergenic T vs. C All: C 15 108,990 0.392 (T) 0.358 (C) 1.07 (1.04-1.11) 0 (0-38) 6.62e-05
rs17488996 chr3:1003642 intergenic T vs. C All: C 15 108,990 0.433 (T) 0.358 (C) 1.07 (1.04-1.11) 0 (0-38) 6.70e-05
rs3804959 chr3:7516145 GRM7 C vs. T All: C 15 108,990 0.292 (C) 0.308 (C) 0.93 (0.90-0.97) 7 (0-43) 1.22e-04
rs3804958 chr3:7516763 GRM7 T vs. C All: C 15 108,990 0.3 (T) 0.3 (T) 0.93 (0.90-0.97) 6 (0-56) 8.75e-05
rs1391902 chr3:7517290 GRM7 C vs. T All: C 15 108,990 0.283 (C) 0.317 (C) 0.93 (0.90-0.97) 5 (0-56) 7.98e-05
rs55787590 chr3:7517972 GRM7 C vs. T All: C 15 108,990 - - 1.07 (1.04-1.11) 5 (0-56) 1.02e-04
rs7610803 chr3:9323523 SRGAP3 G vs. A All: C 15 108,990 - - 1.09 (1.04-1.14) 0 (0-45) 8.78e-05
rs7633558 chr3:9323590 SRGAP3 T vs. C All: C 15 108,990 0.133 (T) 0.083 (T) 0.92 (0.88-0.96) 0 (0-45) 8.97e-05
rs13061863 chr3:9324990 SRGAP3 T vs. C All: C 15 108,990 0.142 (T) 0.083 (T) 0.92 (0.88-0.96) 0 (0-48) 9.06e-05
rs12631463 chr3:9327287 SRGAP3 T vs. C All: C 15 108,990 0.15 (T) 0.083 (T) 0.92 (0.89-0.96) 0 (0-46) 1.69e-04
rs34294409 chr3:9328266 SRGAP3 G vs. A All: C 15 108,990 0.15 (G) 0.075 (G) 0.92 (0.87-0.96) 0 (0-46) 3.45e-04
rs71314335 chr3:9328283 SRGAP3 T vs. C All: C 15 108,990 0.15 (T) 0.075 (T) 0.90 (0.85-0.95) 0 (0-24) 5.75e-05
rs708033 chr3:10249720 IRAK2 T vs. C All: C 15 108,990 0.133 (T) 0.483 (T) 0.91 (0.87-0.96) 30 (0-62) 6.50e-05
rs459864 chr3:10251196 IRAK2 A vs. G All: C 15 108,990 0.15 (A) 0.467 (A) 0.92 (0.88-0.96) 45 (0-70) 2.38e-04
rs2002965 chr3:18201026 TBC1D5 G vs. A All: C 15 108,990 0.092 (G) 0.083 (G) 1.12 (1.06-1.18) 0 (0-22) 2.64e-05
rs1108439 chr3:18201319 TBC1D5 G vs. A All: C 15 108,990 0.092 (G) 0.05 (G) 1.12 (1.06-1.18) 0 (0-34) 2.87e-05
rs7647968 chr3:18240610 TBC1D5 C vs. A All: C 15 108,990 0.45 (C) 0.033 (C) 0.94 (0.91-0.97) 0 (0-50) 9.35e-05
rs4333081 chr3:18245616 TBC1D5 T vs. C All: C 15 108,990 0.125 (T) - 1.10 (1.05-1.15) 0 (0-37) 1.08e-04
rs9817910 chr3:18246870 TBC1D5 G vs. A All: C 15 108,990 0.45 (G) 0.033 (G) 0.94 (0.91-0.97) 0 (0-52) 9.20e-05
rs958542 chr3:18247966 TBC1D5 C vs. T All: C 15 108,990 0.442 (C) 0.033 (C) 0.94 (0.91-0.97) 0 (0-53) 7.48e-05
rs73032587 chr3:18249906 TBC1D5 T vs. C All: C 15 108,990 0.075 (T) - 1.19 (1.10-1.29) 0 (0-49) 9.54e-06
rs17403715 chr3:18254381 TBC1D5 A vs. G All: C 15 108,990 0.133 (A) 0.067 (A) 1.10 (1.05-1.15) 0 (0-37) 8.84e-05
rs9809410 chr3:18257217 TBC1D5 A vs. G All: C 15 108,990 0.458 (A) 0.008 (A) 0.94 (0.91-0.97) 0 (0-53) 7.43e-05
rs13060052 chr3:18257585 TBC1D5 A vs. C All: C 15 108,990 0.133 (A) 0.092 (A) 1.10 (1.05-1.15) 0 (0-37) 8.63e-05
rs13071572 chr3:18259222 TBC1D5 T vs. G All: C 15 108,990 0.133 (T) 0.075 (T) 1.10 (1.05-1.15) 0 (0-38) 8.54e-05
rs11916671 chr3:18262938 TBC1D5 C vs. A All: C 15 108,990 0.45 (C) 0.033 (C) 0.94 (0.91-0.97) 0 (0-53) 5.95e-05
rs9824915 chr3:18263272 TBC1D5 T vs. G All: C 15 108,990 0.125 (T) 0.108 (T) 1.10 (1.05-1.15) 0 (0-38) 8.17e-05
rs73034316 chr3:18268543 TBC1D5 A vs. G All: C 15 108,990 0.117 (A) 0.067 (A) 1.10 (1.05-1.15) 0 (0-38) 7.41e-05
rs7430448 chr3:18270546 TBC1D5 C vs. T All: C 15 108,990 0.458 (C) 0.033 (C) 0.94 (0.91-0.97) 0 (0-52) 1.22e-04